Annegret Lamadé is an associate in the Hamburg office of Latham & Watkins.
Annegret advises German and international clients primarily on all health-related matters with focus on the pharmaceutical and medical technology sectors. She advises on domestic and cross-border M&A transactions and strategic collaborations, including product divestitures, carve-outs, licensing arrangements, and other complex transactions in the healthcare and life sciences sector. In addition, she advises clients on complex regulatory projects and compliance matters, including market access strategies, product lifecycle management, digital health, AI regulation, and large-scale remediation projects.
Annegret studied law at the University of Marburg, specializing in medical and pharmaceutical law. She completed her legal clerkship at the Hanseatic Higher Regional Court in Hamburg, including placements with international law firms in the healthcare and life sciences sector and the German Federal Foreign Office in Los Angeles. She holds a Ph.D. focusing on the conformity assessment of AI-based medical devices.